{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:49:53Z","timestamp":1790621393257,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T00:00:00Z","timestamp":1777852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM147118"],"award-info":[{"award-number":["R35GM147118"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM007270"],"award-info":[{"award-number":["T32GM007270"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA015704"],"award-info":[{"award-number":["P30CA015704"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Decreased availability of the amino acid aspartate constrains cell function across diverse biological contexts, but the temporal interplay between aspartate abundance, downstream metabolic changes and functional effects remains poorly understood. Here we show that succinate dehydrogenase (SDH) inhibition suppresses pyrimidine synthesis via dual effects of cellular aspartate depletion and succinate accumulation. Using an aspartate biosensor and live-cell imaging, we monitor aspartate levels and cell proliferation across several models of aspartate limitation. While complex I inhibition or knockout of aspartate biosynthetic enzymes lead to a strict decrease in aspartate levels and impair proliferation, SDH inhibition produces a unique aspartate rebound, yet fails to restore proliferation. Mechanistically, we find that SDH loss impairs pyrimidine biosynthesis via succinate accumulation, which competitively inhibits aspartate utilization by mammalian aspartate transcarbamylase (ATCase), a key step in pyrimidine biosynthesis. This metabolic interaction occurs in multiple models of SDH deficiency, causing pyrimidine insufficiency, replication stress and sensitivity to ATR kinase inhibition. Taken together, these findings define an unexpected role for succinate in modulating cellular nucleotide homeostasis and demonstrate how cascading metabolic interactions can unfold to impact cell function.<\/jats:p>","DOI":"10.1038\/s42255-026-01524-w","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:02:36Z","timestamp":1777885356000},"page":"1390-1409","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Succinate dehydrogenase loss suppresses pyrimidine biosynthesis via succinate-mediated inhibition of aspartate transcarbamylase"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9125-0627","authenticated-orcid":false,"given":"Madeleine L.","family":"Hart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6774-4133","authenticated-orcid":false,"given":"David","family":"Sokolov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serwah","family":"Danquah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex D.","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Davidsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"MacPherson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-8222","authenticated-orcid":false,"given":"Lucas B.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,4]]},"reference":[{"key":"1524_CR1","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.cell.2016.02.058","volume":"164","author":"M Shamir","year":"2016","unstructured":"Shamir, M., Bar-On, Y., Phillips, R. & Milo, R. SnapShot: timescales in cell biology. Cell 164, 1302\u20131302.e1 (2016).","journal-title":"Cell"},{"key":"1524_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.cell.2015.07.017","volume":"162","author":"LB Sullivan","year":"2015","unstructured":"Sullivan, L. B. et al. Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells. Cell 162, 552\u2013563 (2015).","journal-title":"Cell"},{"key":"1524_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","volume":"162","author":"K Birsoy","year":"2015","unstructured":"Birsoy, K. et al. An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis. Cell 162, 540\u2013551 (2015).","journal-title":"Cell"},{"key":"1524_CR4","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cmet.2016.09.006","volume":"24","author":"DY Gui","year":"2016","unstructured":"Gui, D. Y. et al. Environment dictates dependence on mitochondrial complex I for NAD+ and aspartate production and determines cancer cell sensitivity to metformin. Cell Metab. 24, 716\u2013727 (2016).","journal-title":"Cell Metab."},{"key":"1524_CR5","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1038\/s41556-018-0125-0","volume":"20","author":"LB Sullivan","year":"2018","unstructured":"Sullivan, L. B. et al. Aspartate is an endogenous metabolic limitation for tumour growth. Nat. Cell Biol. 20, 782\u2013788 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1524_CR6","doi-asserted-by":"publisher","first-page":"8784","DOI":"10.1038\/ncomms9784","volume":"6","author":"C Lussey-Lepoutre","year":"2015","unstructured":"Lussey-Lepoutre, C. et al. Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism. Nat. Commun. 6, 8784 (2015).","journal-title":"Nat. Commun."},{"key":"1524_CR7","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.78654","volume":"12","author":"ML Hart","year":"2023","unstructured":"Hart, M. L. et al. Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells. eLife 12, e78654 (2023).","journal-title":"eLife"},{"key":"1524_CR8","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/ncb3233","volume":"17","author":"S Cardaci","year":"2015","unstructured":"Cardaci, S. et al. Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis. Nat. Cell Biol. 17, 1317\u20131326 (2015).","journal-title":"Nat. Cell Biol."},{"key":"1524_CR9","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.49178","volume":"9","author":"E Mick","year":"2020","unstructured":"Mick, E. et al. Distinct mitochondrial defects trigger the integrated stress response depending on the metabolic state of the cell. eLife 9, e49178 (2020).","journal-title":"eLife"},{"key":"1524_CR10","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/j.stem.2021.07.011","volume":"28","author":"L Qi","year":"2021","unstructured":"Qi, L. et al. Aspartate availability limits hematopoietic stem cell function during hematopoietic regeneration. Cell Stem Cell 28, 1982\u20131999.e8 (2021).","journal-title":"Cell Stem Cell"},{"key":"1524_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/s41556-018-0118-z","volume":"20","author":"J Garcia-Bermudez","year":"2018","unstructured":"Garcia-Bermudez, J. et al. Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours. Nat. Cell Biol. 20, 775\u2013781 (2018).","journal-title":"Nat. Cell Biol."},{"key":"1524_CR12","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s42255-022-00583-z","volume":"4","author":"J Garcia-Bermudez","year":"2022","unstructured":"Garcia-Bermudez, J. et al. Adaptive stimulation of macropinocytosis overcomes aspartate limitation in cancer cells under hypoxia. Nat. Metab. 4, 724\u2013738 (2022).","journal-title":"Nat. Metab."},{"key":"1524_CR13","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1158\/0008-5472.CAN-20-0246","volume":"80","author":"HR Madala","year":"2020","unstructured":"Madala, H. R. et al. Nitrogen trapping as a therapeutic strategy in tumors with mitochondrial dysfunction. Cancer Res. 80, 3492\u20133506 (2020).","journal-title":"Cancer Res."},{"key":"1524_CR14","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.73245","volume":"11","author":"SA Kerk","year":"2022","unstructured":"Kerk, S. A. et al. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. eLife 11, e73245 (2022).","journal-title":"eLife"},{"key":"1524_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-60204-7","volume":"16","author":"MR Teh","year":"2025","unstructured":"Teh, M. R. et al. Iron deficiency causes aspartate-sensitive dysfunction in CD8+ T cells. Nat. Commun. 16, 5355 (2025).","journal-title":"Nat. Commun."},{"key":"1524_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.cmet.2018.07.021","volume":"28","author":"HF Alkan","year":"2018","unstructured":"Alkan, H. F. et al. Cytosolic aspartate availability determines cell survival when glutamine is limiting. Cell Metab. 28, 706\u2013720.e6 (2018).","journal-title":"Cell Metab."},{"key":"1524_CR17","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.celrep.2019.01.106","volume":"26","author":"F Mel\u00e9ndez-Rodr\u00edguez","year":"2019","unstructured":"Mel\u00e9ndez-Rodr\u00edguez, F. et al. HIF1\u03b1 suppresses tumor cell proliferation through inhibition of aspartate biosynthesis. Cell Rep. 26, 2257\u20132265.e4 (2019).","journal-title":"Cell Rep."},{"key":"1524_CR18","doi-asserted-by":"publisher","first-page":"4537","DOI":"10.1016\/j.molcel.2022.10.005","volume":"82","author":"P Altea-Manzano","year":"2022","unstructured":"Altea-Manzano, P. et al. Reversal of mitochondrial malate dehydrogenase 2 enables anaplerosis via redox rescue in respiration-deficient cells. Mol. Cell 82, 4537\u20134547.e7 (2022).","journal-title":"Mol. Cell"},{"key":"1524_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/s42003-018-0178-4","volume":"1","author":"C-T Cheng","year":"2018","unstructured":"Cheng, C.-T. et al. Arginine starvation kills tumor cells through aspartate exhaustion and mitochondrial dysfunction. Commun. Biol. 1, 178 (2018).","journal-title":"Commun. Biol."},{"key":"1524_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.devcel.2022.04.018","volume":"57","author":"RE Oberkersch","year":"2022","unstructured":"Oberkersch, R. E. et al. Aspartate metabolism in endothelial cells activates the mTORC1 pathway to initiate translation during angiogenesis. Dev. Cell 57, 1241\u20131256.e8 (2022).","journal-title":"Dev. Cell"},{"key":"1524_CR21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-1311-3","volume":"571","author":"W Bailis","year":"2019","unstructured":"Bailis, W. et al. Distinct modes of mitochondrial metabolism uncouple T cell differentiation and function. Nature 571, 403\u2013407 (2019).","journal-title":"Nature"},{"key":"1524_CR22","doi-asserted-by":"publisher","unstructured":"Davidsen, K., Marvin, J. S., Aggarwal, A., Brown, T. A. & Sullivan, L. B. An engineered biosensor enables dynamic aspartate measurements in living cells. eLife https:\/\/doi.org\/10.7554\/eLife.90024 (2023).","DOI":"10.7554\/eLife.90024"},{"key":"1524_CR23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1210\/en.2013-1549","volume":"155","author":"N Lendvai","year":"2014","unstructured":"Lendvai, N. et al. Succinate-to-fumarate ratio as a new metabolic marker to detect the presence of SDHB\/D-related paraganglioma: initial experimental and ex vivo findings. Endocrinology 155, 27\u201332 (2014).","journal-title":"Endocrinology"},{"key":"1524_CR24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.91554.3","volume":"12","author":"K Davidsen","year":"2024","unstructured":"Davidsen, K. & Sullivan, L. B. A robust method for measuring aminoacylation through tRNA-seq. eLife 12, RP91554 (2024).","journal-title":"eLife"},{"key":"1524_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nature15529","volume":"527","author":"S Rabinovich","year":"2015","unstructured":"Rabinovich, S. et al. Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis. Nature 527, 379\u2013383 (2015).","journal-title":"Nature"},{"key":"1524_CR26","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0304-3835(89)90019-0","volume":"46","author":"E de Kant","year":"1989","unstructured":"de Kant, E., Pinedo, H. M., Laurensse, E. & Peters, G. J. The relation between inhibition of cell growth and of dihydroorotic acid dehydrogenase by brequinar sodium. Cancer Lett. 46, 123\u2013127 (1989).","journal-title":"Cancer Lett."},{"key":"1524_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61242-x","volume":"16","author":"H Zhang","year":"2025","unstructured":"Zhang, H. et al. De novo pyrimidine biosynthesis inhibition synergizes with BCL-XL targeting in pancreatic cancer. Nat. Commun. 16, 6987 (2025).","journal-title":"Nat. Commun."},{"key":"1524_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215981","volume":"552","author":"NJ Mullen","year":"2023","unstructured":"Mullen, N. J. et al. ENT1 blockade by CNX-774 overcomes resistance to DHODH inhibition in pancreatic cancer. Cancer Lett. 552, 215981 (2023).","journal-title":"Cancer Lett"},{"key":"1524_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2019.04.013","author":"E Dalla Pozza","year":"2019","unstructured":"Dalla Pozza, E. et al. Regulation of succinate dehydrogenase and role of succinate in cancer. Semin. Cell Dev. Biol. https:\/\/doi.org\/10.1016\/j.semcdb.2019.04.013 (2019).","journal-title":"Semin. Cell Dev. Biol."},{"key":"1524_CR30","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nprot.2008.107","volume":"3","author":"BD Bennett","year":"2008","unstructured":"Bennett, B. D., Yuan, J., Kimball, E. H. & Rabinowitz, J. D. Absolute quantitation of intracellular metabolite concentrations by an isotope ratio-based approach. Nat. Protoc. 3, 1299\u20131311 (2008).","journal-title":"Nat. Protoc."},{"key":"1524_CR31","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1016\/j.molcel.2025.10.002","volume":"85","author":"MA Nengroo","year":"2025","unstructured":"Nengroo, M. A. et al. Accumulation of succinate suppresses de novo purine synthesis through succinylation-mediated control of the mitochondrial folate cycle. Mol. Cell 85, 4215\u20134228.e9 (2025).","journal-title":"Mol. Cell"},{"key":"1524_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","volume":"50","author":"PL Sulkowski","year":"2018","unstructured":"Sulkowski, P. L. et al. Krebs cycle-deficient hereditary cancer syndromes are defined by homologous recombination DNA repair defects. Nat. Genet. 50, 1086\u20131092 (2018).","journal-title":"Nat. Genet."},{"key":"1524_CR33","doi-asserted-by":"publisher","first-page":"3903","DOI":"10.1210\/jc.2014-2151","volume":"99","author":"S Richter","year":"2014","unstructured":"Richter, S. et al. Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas\/paragangliomas due to succinate dehydrogenase deficiency. J. Clin. Endocrinol. Metab. 99, 3903\u20133911 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1524_CR34","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","volume":"23","author":"E Letouz\u00e9","year":"2013","unstructured":"Letouz\u00e9, E. et al. SDH mutations establish a hypermethylator phenotype in paraganglioma. Cancer Cell 23, 739\u2013752 (2013).","journal-title":"Cancer Cell"},{"key":"1524_CR35","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/S0021-9258(18)91759-X","volume":"244","author":"RW Porter","year":"1969","unstructured":"Porter, R. W., Modebe, M. O. & Stark, G. R. Aspartate transcarbamylase: kinetic studies of the catalytic subunit. J. Biol. Chem. 244, 1846\u20131859 (1969).","journal-title":"J. Biol. Chem."},{"key":"1524_CR36","doi-asserted-by":"publisher","first-page":"6599","DOI":"10.1016\/S0021-9258(19)34156-0","volume":"246","author":"KD Collins","year":"1971","unstructured":"Collins, K. D. & Stark, G. R. Aspartate transcarbamylase: interaction with the transition state analogue N-(phosphonacetyl)-L-aspartate. J. Biol. Chem. 246, 6599\u20136605 (1971).","journal-title":"J. Biol. Chem."},{"key":"1524_CR37","doi-asserted-by":"publisher","first-page":"9624","DOI":"10.1016\/S0021-9258(17)39283-9","volume":"260","author":"J Foote","year":"1985","unstructured":"Foote, J., Lauritzen, A. M. & Lipscomb, W. N. Substrate specificity of aspartate transcarbamylase. Interaction of the enzyme with analogs of aspartate and succinate. J. Biol. Chem. 260, 9624\u20139629 (1985).","journal-title":"J. Biol. Chem."},{"key":"1524_CR38","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.str.2016.05.001","volume":"24","author":"A Ruiz-Ramos","year":"2016","unstructured":"Ruiz-Ramos, A., Vel\u00e1zquez-Campoy, A., Grande-Garc\u00eda, A., Moreno-Morcillo, M. & Ram\u00f3n-Maiques, S. Structure and functional characterization of human aspartate transcarbamoylase, the target of the anti-tumoral drug PALA. Structure 24, 1081\u20131094 (2016).","journal-title":"Structure"},{"key":"1524_CR39","doi-asserted-by":"crossref","unstructured":"Del Ca\u00f1o-Ochoa, F., Moreno-Morcillo, M. & Ram\u00f3n-Maiques, S. in Macromolecular Protein Complexes II: Structure and Function Subcellular Biochemistry (eds Harris, J. R. & Marles-Wright, J.) 505\u2013538 (Springer International Publishing, 2019).","DOI":"10.1007\/978-3-030-28151-9_17"},{"key":"1524_CR40","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1021\/ar200166p","volume":"45","author":"WN Lipscomb","year":"2012","unstructured":"Lipscomb, W. N. & Kantrowitz, E. R. Structure and mechanisms of Escherichia coli Aspartate transcarbamoylase. Acc. Chem. Res. 45, 444\u2013453 (2012).","journal-title":"Acc. Chem. Res."},{"key":"1524_CR41","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0003-2697(90)90069-L","volume":"186","author":"AJ Else","year":"1990","unstructured":"Else, A. J. & Herv\u00e9, G. A microtiter plate assay for aspartate transcarbamylase. Anal. Biochem. 186, 219\u2013221 (1990).","journal-title":"Anal. Biochem."},{"key":"1524_CR42","doi-asserted-by":"publisher","first-page":"6945","DOI":"10.1016\/S0021-9258(19)42149-2","volume":"249","author":"EA Swyryd","year":"1974","unstructured":"Swyryd, E. A., Seaver, S. S. & Stark, G. R. N-(phosphonacetyl)-L-aspartate, a potent transition state analog inhibitor of aspartate transcarbamylase, blocks proliferation of mammalian cells in culture. J. Biol. Chem. 249, 6945\u20136950 (1974).","journal-title":"J. Biol. Chem."},{"key":"1524_CR43","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1002\/pro.4158","volume":"30","author":"F Del Ca\u00f1o-Ochoa","year":"2021","unstructured":"Del Ca\u00f1o-Ochoa, F. & Ram\u00f3n-Maiques, S. Deciphering CAD: structure and function of a mega-enzymatic pyrimidine factory in health and disease. Protein Sci. 30, 1995\u20132008 (2021).","journal-title":"Protein Sci."},{"key":"1524_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ymben.2016.11.005","volume":"43","author":"D Lorendeau","year":"2017","unstructured":"Lorendeau, D. et al. Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors. Metab. Eng. 43, 187\u2013197 (2017).","journal-title":"Metab. Eng."},{"key":"1524_CR45","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.euf.2021.12.002","volume":"8","author":"A Yoo","year":"2022","unstructured":"Yoo, A. et al. Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas. Eur. Urol. Focus 8, 1278\u20131288 (2022).","journal-title":"Eur. Urol. Focus"},{"key":"1524_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford, A. N. & Jackson, S. P. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol. Cell 66, 801\u2013817 (2017).","journal-title":"Mol. Cell"},{"key":"1524_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard, H., Garc\u00eda-Muse, T. & Aguilera, A. Replication stress and cancer. Nat. Rev. Cancer 15, 276\u2013289 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"1524_CR48","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.devcel.2024.05.010","volume":"59","author":"BT Do","year":"2024","unstructured":"Do, B. T. et al. Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress. Dev. Cell 59, 2203\u20132221.e15 (2024).","journal-title":"Dev. Cell"},{"key":"1524_CR49","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1038\/s41556-022-00965-1","volume":"24","author":"FF Diehl","year":"2022","unstructured":"Diehl, F. F. et al. Nucleotide imbalance decouples cell growth from cell proliferation. Nat. Cell Biol. 24, 1252\u20131264 (2022).","journal-title":"Nat. Cell Biol."},{"key":"1524_CR50","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1038\/nrm1493","volume":"5","author":"J Bartek","year":"2004","unstructured":"Bartek, J., Lukas, C. & Lukas, J. Checking on DNA damage in S phase. Nat. Rev. Mol. Cell Biol. 5, 792\u2013804 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1524_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/B978-0-12-380888-2.00003-0","volume":"108","author":"J Smith","year":"2010","unstructured":"Smith, J., Tho, L. M., Xu, N. & Gillespie, D. A. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv. Cancer Res. 108, 73\u2013112 (2010).","journal-title":"Adv. Cancer Res."},{"key":"1524_CR52","doi-asserted-by":"publisher","first-page":"a012716","DOI":"10.1101\/cshperspect.a012716","volume":"5","author":"A Mar\u00e9chal","year":"2013","unstructured":"Mar\u00e9chal, A. & Zou, L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol. 5, a012716 (2013).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1524_CR53","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.chembiol.2019.10.012","volume":"27","author":"ER Abt","year":"2020","unstructured":"Abt, E. R. et al. Metabolic modifier screen reveals secondary targets of protein kinase inhibitors within nucleotide metabolism. Cell Chem. Biol. 27, 197\u2013205.e6 (2020).","journal-title":"Cell Chem. Biol"},{"key":"1524_CR54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/1535-7163.MCT-19-0019","volume":"19","author":"AM Wengner","year":"2020","unstructured":"Wengner, A. M. et al. The novel ATR inhibitor BAY 1895344 is efficacious as monotherapy and combined with DNA damage-inducing or repair-compromising therapies in preclinical cancer models. Mol. Cancer Ther. 19, 26\u201338 (2020).","journal-title":"Mol. Cancer Ther."},{"key":"1524_CR55","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.4161\/cbt.21093","volume":"13","author":"R Prevo","year":"2012","unstructured":"Prevo, R. et al. The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. Cancer Biol. Ther. 13, 1072\u20131081 (2012).","journal-title":"Cancer Biol. Ther."},{"key":"1524_CR56","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","volume":"38","author":"AJ Gill","year":"2014","unstructured":"Gill, A. J. et al. Succinate dehydrogenase deficiency is rare in pituitary adenomas. Am. J. Surg. Pathol. 38, 560\u2013566 (2014).","journal-title":"Am. J. Surg. Pathol."},{"key":"1524_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1086\/321282","volume":"69","author":"D Astuti","year":"2001","unstructured":"Astuti, D. et al. Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am. J. Hum. Genet. 69, 49\u201354 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"1524_CR58","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1126\/science.287.5454.848","volume":"287","author":"BE Baysal","year":"2000","unstructured":"Baysal, B. E. et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287, 848\u2013851 (2000).","journal-title":"Science"},{"key":"1524_CR59","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/81551","volume":"26","author":"S Niemann","year":"2000","unstructured":"Niemann, S. & M\u00fcller, U. Mutations in SDHC cause autosomal dominant paraganglioma, type 3. Nat. Genet. 26, 268\u2013270 (2000).","journal-title":"Nat. Genet."},{"key":"1524_CR60","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1073\/pnas.1009199108","volume":"108","author":"KA Janeway","year":"2011","unstructured":"Janeway, K. A. et al. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc. Natl Acad. Sci. USA 108, 314\u2013318 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1524_CR61","doi-asserted-by":"publisher","first-page":"E710","DOI":"10.1210\/jc.2014-4297","volume":"100","author":"P Xekouki","year":"2015","unstructured":"Xekouki, P. et al. Pituitary adenoma with paraganglioma\/pheochromocytoma (3PAs) and succinate dehydrogenase defects in humans and mice. J. Clin. Endocrinol. Metab. 100, E710\u2013E719 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1524_CR62","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.bbabio.2011.07.003","volume":"1807","author":"C Bardella","year":"2011","unstructured":"Bardella, C., Pollard, P. J. & Tomlinson, I. SDH mutations in cancer. Biochim. Biophys. Acta 1807, 1432\u20131443 (2011).","journal-title":"Biochim. Biophys. Acta"},{"key":"1524_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110453","volume":"38","author":"N Armstrong","year":"2022","unstructured":"Armstrong, N. et al. SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB\/NF1 loss yields SDHx-like pheochromocytomas. Cell Rep. 38, 110453 (2022).","journal-title":"Cell Rep."},{"key":"1524_CR64","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.cell.2018.03.055","volume":"173","author":"C Jang","year":"2018","unstructured":"Jang, C., Chen, L. & Rabinowitz, J. D. Metabolomics and isotope tracing. Cell 173, 822\u2013837 (2018).","journal-title":"Cell"},{"key":"1524_CR65","doi-asserted-by":"publisher","unstructured":"Eijkelenkamp, K., Osinga, T. E., Links, T. P. & van der Horst-Schrivers, A. N. A. Clinical implications of the oncometabolite succinate in SDHx-mutation carriers. Clin. Genet. https:\/\/doi.org\/10.1111\/cge.13553 (2019).","DOI":"10.1111\/cge.13553"},{"key":"1524_CR66","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature13909","volume":"515","author":"ET Chouchani","year":"2014","unstructured":"Chouchani, E. T. et al. Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature 515, 431\u2013435 (2014).","journal-title":"Nature"},{"key":"1524_CR67","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496, 238\u2013242 (2013).","journal-title":"Nature"},{"key":"1524_CR68","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/nrc.2016.85","volume":"16","author":"LB Sullivan","year":"2016","unstructured":"Sullivan, L. B., Gui, D. Y. & Vander Heiden, M. G. Altered metabolite levels in cancer: implications for tumour biology and cancer therapy. Nat. Rev. Cancer 16, 680\u2013693 (2016).","journal-title":"Nat. Rev. Cancer"},{"key":"1524_CR69","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167, 457\u2013470.e13 (2016).","journal-title":"Cell"},{"key":"1524_CR70","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41590-019-0372-7","volume":"20","author":"N Keiran","year":"2019","unstructured":"Keiran, N. et al. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity. Nat. Immunol. 20, 581\u2013592 (2019).","journal-title":"Nat. Immunol."},{"key":"1524_CR71","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-018-0353-2","volume":"560","author":"EL Mills","year":"2018","unstructured":"Mills, E. L. et al. Accumulation of succinate controls activation of adipose tissue thermogenesis. Nature 560, 102\u2013106 (2018).","journal-title":"Nature"},{"key":"1524_CR72","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s42255-018-0014-7","volume":"1","author":"DG Ryan","year":"2019","unstructured":"Ryan, D. G. et al. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat Metab. 1, 16\u201333 (2019).","journal-title":"Nat Metab"},{"key":"1524_CR73","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3390\/metabo10090372","volume":"10","author":"KJ Harber","year":"2020","unstructured":"Harber, K. J. et al. Succinate is an inflammation-induced immunoregulatory metabolite in macrophages. Metabolites 10, 372 (2020).","journal-title":"Metabolites"},{"key":"1524_CR74","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cell.2020.08.039","volume":"183","author":"A Reddy","year":"2020","unstructured":"Reddy, A. et al. pH-gated succinate secretion regulates muscle remodeling in response to exercise. Cell 183, 62\u201375.e17 (2020).","journal-title":"Cell"},{"key":"1524_CR75","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s42255-021-00389-5","volume":"3","author":"EL Mills","year":"2021","unstructured":"Mills, E. L. et al. UCP1 governs liver extracellular succinate and inflammatory pathogenesis. Nat. Metab. 3, 604\u2013617 (2021).","journal-title":"Nat. Metab."},{"key":"1524_CR76","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s42255-024-00981-5","volume":"6","author":"A Reddy","year":"2024","unstructured":"Reddy, A. et al. Monocarboxylate transporters facilitate succinate uptake into brown adipocytes. Nat. Metab. 6, 567\u2013577 (2024).","journal-title":"Nat. Metab."},{"key":"1524_CR77","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1158\/2159-8290.CD-22-0874","volume":"13","author":"BR Wilde","year":"2023","unstructured":"Wilde, B. R. et al. FH variant pathogenicity promotes purine salvage pathway dependence in kidney cancer. Cancer Discov. 13, 2072\u20132089 (2023).","journal-title":"Cancer Discov."},{"key":"1524_CR78","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/j.cmet.2024.05.014","volume":"36","author":"Z Wu","year":"2024","unstructured":"Wu, Z. et al. Electron transport chain inhibition increases cellular dependence on purine transport and salvage. Cell. Metab. 36, 1504\u20131520.e9 (2024).","journal-title":"Cell. Metab"},{"key":"1524_CR79","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1016\/j.cell.2024.05.011","volume":"187","author":"DH Tran","year":"2024","unstructured":"Tran, D. H. et al. De novo and salvage purine synthesis pathways across tissues and tumors. Cell 187, 3602\u20133618.e20 (2024).","journal-title":"Cell"},{"key":"1524_CR80","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.18632\/oncotarget.28273","volume":"13","author":"D Ueno","year":"2022","unstructured":"Ueno, D. et al. Targeting Krebs-cycle-deficient renal cell carcinoma with poly ADP-ribose polymerase inhibitors and low-dose alkylating chemotherapy. Oncotarget 13, 1054\u20131067 (2022).","journal-title":"Oncotarget"},{"key":"1524_CR81","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1038\/s42255-024-01166-w","volume":"6","author":"M Nam","year":"2024","unstructured":"Nam, M. et al. Glucose limitation protects cancer cells from apoptosis induced by pyrimidine restriction and replication inhibition. Nat. Metab. 6, 2338\u20132353 (2024).","journal-title":"Nat. Metab."},{"key":"1524_CR82","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41419-025-07334-4","volume":"16","author":"XH Zhao","year":"2025","unstructured":"Zhao, X. H. et al. DNA replication stress underpins the vulnerability to oxidative phosphorylation inhibition in colorectal cancer. Cell Death Dis. 16, 16 (2025).","journal-title":"Cell Death Dis."},{"key":"1524_CR83","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"1524_CR84","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open Babel: an open chemical toolbox. J. Cheminform. 3, 33 (2011).","journal-title":"J. Cheminform."},{"key":"1524_CR85","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1107\/S1744309113031114","volume":"69","author":"A Ruiz-Ramos","year":"2013","unstructured":"Ruiz-Ramos, A., Lallous, N., Grande-Garc\u00eda, A. & Ram\u00f3n-Maiques, S. Expression, purification, crystallization and preliminary X-ray diffraction analysis of the aspartate transcarbamoylase domain of human CAD. Acta Crystallogr. F Struct. Biol. Cryst. Commun. 69, 1425\u20131430 (2013).","journal-title":"Acta Crystallogr. F Struct. Biol. Cryst. Commun."},{"key":"1524_CR86","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","volume":"41","author":"FW Studier","year":"2005","unstructured":"Studier, F. W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41, 207\u2013234 (2005).","journal-title":"Protein Expr. Purif"},{"key":"1524_CR87","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/S0003-2697(69)80008-4","volume":"32","author":"LM Prescott","year":"1969","unstructured":"Prescott, L. M. & Jones, M. E. Modified methods for the determination of carbamyl aspartate. Anal. Biochem. 32, 408\u2013419 (1969).","journal-title":"Anal. Biochem."},{"key":"1524_CR88","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkaf540","volume":"53","author":"JJ Readshaw","year":"2025","unstructured":"Readshaw, J. J. et al. PglZ from Type I BREX phage defence systems is a metal-dependent nuclease that forms a sub-complex with BrxB. Nucleic Acids Res. 53, gkaf540 (2025).","journal-title":"Nucleic Acids Res."},{"key":"1524_CR89","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adt3177","volume":"11","author":"B Freie","year":"2024","unstructured":"Freie, B. et al. MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues. Sci. Adv. 11, eadt3177 (2024).","journal-title":"Sci. Adv."}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01524-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01524-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:02:28Z","timestamp":1782396148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-026-01524-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":89,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["1524"],"URL":"https:\/\/doi.org\/10.1038\/s42255-026-01524-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.18.638948","asserted-by":"object"}]},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}